Loading
Adipokines, Inflammation, and Metabolic Diseases / Regulation of Appetite and Obesity · Journal article
American Journal of Physiology-endocrinology and Metabolism · August 17, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review that integrates proposed biomolecular mechanisms—including SIK2/3 transcriptional repression, ACBP-mediated suppression of lipolysis, and immune-mediated regulation—to explain why brown adipose tissue thermogenic function declines with aging and obesity. The work is mechanistic and conceptual; it does not report empirical results, patient cohorts, or quantified outcomes, and therefore represents a synthesis of hypotheses rather than evidence answering a clinical question.
Narrative review. Conceptual framework applicable to aging and obese populations; no empirical cohort studied..
Brown adipose tissue activity progressively declines with advancing age and excess adiposity Three major regulatory domains identified: intracellular thermogenic signaling (SIK2/3 as UCP1 repressors), autophagy-dependent ACBP secretion (suppresses lipolysis and thermogenic signaling), and immune-mediated regulation involving NLRP3-MAOA, SLIT3/ETS1, PEPD, and IgG pathways Aging and obesity impose coordinated constraints on brown and beige adipose tissue activation through convergent mechanisms
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review frames thermogenic decline as a regulated biological process and suggests future research directions to preserve metabolic flexibility in aging. However, it does not provide evidence to guide clinical practice, as no human outcomes, therapeutic interventions, or quantified effects are reported.
A narrative review synthesizing mechanistic pathways in preclinical and cell biology without reporting clinical trials, patient outcomes, or quantified human data; raises questions about regulatory mechanisms rather than answering them in humans.
As stated by the source record.
This review frames thermogenic decline as a regulated biological process and suggests future research directions to preserve metabolic flexibility in aging. However, it does not provide evidence to guide clinical practice, as no human outcomes, therapeutic interventions, or quantified effects are reported.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Population aging is accelerating worldwide, and is accompanied by a growing burden of chronic metabolic diseases. Adipose tissue dysfunction represents a central mechanism linking aging and obesity to metabolic decline, contributing to chronic low-grade inflammation, impaired adipokine signaling, ectopic lipid deposition, and the whitening of thermogenic fat depots. Brown adipose tissue (BAT) plays a key role in adaptive thermogenesis through UCP1 mediated mitochondrial uncoupling, however, its activity progressively declines with advancing age and excess adiposity. This narrative review synthesizes emerging biomolecular mechanisms that underlie impaired thermogenic function in the context of aging and obesity. We integrate evidence across three major regulatory domains: (1) intracellular thermogenic signaling, highlighting salt-inducible kinases (SIK2/3), as transcriptional repressors that limit UCP1 expression when ß3-adrenergic/PKA signaling is impaired, (2) autophagy-dependent secretion of acyl-CoA binding protein (ACBP), which suppresses lipolysis, ß-oxidation, and thermogenic signaling and may contribute to BAT whitening, and (3) immune mediated regulation of thermogenic adipose tissue, with macrophage modulating sympathetic signaling, inflammatory tone, and extracellular matrix remodeling through pathways involving NLRP3-MAOA, SLIT3/ETS1, prolidase (PEPD) and immunoglobulin G (IgG). Collectively, these convergent mechanisms illustrate how aging and obesity impose coordinated constraints on brown and beige adipose tissue activation. By framing thermogenic decline as a regulated process, this review provides a conceptual basis for future studies aimed at preserving metabolic flexibility and promoting healthier aging.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.